AG
HAE icon

Advisor Group’s Haemonetics HAE Stock Holding History

Advisor Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$524K Buy
4,559
+173
+4% +$20.9K ﹤0.01% 1634
2019
Q3 		$553K Buy
4,386
+1,794
+69% +$228K ﹤0.01% 1538
2019
Q2 		$313K Sell
2,592
-2,822
-52% -$278K ﹤0.01% 1965
2019
Q1 		$473K Buy
5,414
+3,392
+168% +$308K ﹤0.01% 1631
2018
Q4 		$203K Buy
2,022
+1,739
+614% +$183K ﹤0.01% 2077
2018
Q3 		$32K Buy
283
+6
+2% +$621 ﹤0.01% 3587
2018
Q2 		$25K Sell
277
-838
-75% -$70.8K ﹤0.01% 3572
2018
Q1 		$81K Sell
1,115
-19
-2% -$1.3K ﹤0.01% 2722
2017
Q4 		$66K Sell
1,134
-9
-0.8% -$474 ﹤0.01% 2885
2017
Q3 		$51K Sell
1,143
-74
-6% -$3.08K ﹤0.01% 2922
2017
Q2 		$48K Buy
1,217
+49
+4% +$2.01K ﹤0.01% 2878
2017
Q1 		$47K Buy
1,168
+14
+1% +$547 ﹤0.01% 2758
2016
Q4 		$46K Sell
1,154
-418
-27% -$15.8K ﹤0.01% 2670
2016
Q3 		$57K Sell
1,572
-118
-7% -$4.05K ﹤0.01% 2425
2016
Q2 		$48K Buy
+1,690
New +$51.1K ﹤0.01% 2442

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Advisor Group's HAE Position: Q4 2019 in Review

Advisor Group increased its Haemonetics (HAE) stake by 3.9% in Q4 2019, buying an estimated $20.9K and bringing the position to 4,559 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

Advisor Group first reported a position in HAE in Q2 2016 and has held it in 15 quarters since. The position peaked at $553K in Q3 2019. 298 funds tracked by Wall St. Rank hold HAE as of Q4 2019.

  • Advisor Group held 4,559 shares of Haemonetics worth $524K as of Q4 2019.
  • Advisor Group bought 173 Haemonetics shares in Q4 2019, an estimated $20.9K.
  • Haemonetics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1634 holding.
  • Advisor Group first reported a position in Haemonetics in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Haemonetics position peaked at $553K in Q3 2019.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.